UBE2T promotes glioblastoma malignancy through ubiquitination‐mediated degradation of RPL6

Glioblastoma (GBM) is the most frequent and aggressive malignant glioma. Due to patients’ poor prognosis, it is of great clinical significance to determine new targets that may improve GBM treatment. In the present study, we showed that ubiquitin (Ub)‐conjugating enzyme E2T (UBE2T) was significantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Xuxiu, Wu, Xia, Zhou, Peijun, Yu, Xuehui, Zhao, Chen, Peng, Xingzhi, Zhang, Kun, Shen, Liangfang, Peng, Jinwu, Yang, Lifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899609/
https://www.ncbi.nlm.nih.gov/pubmed/36156329
http://dx.doi.org/10.1111/cas.15604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899609/
https://www.ncbi.nlm.nih.gov/pubmed/36156329
http://dx.doi.org/10.1111/cas.15604

Ejemplares similares